Chemesis International Inc. Provides Corporate Update
Chemesis International Inc. Provides Corporate Update
February 3, 2020
Vancouver, BC – Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “ Company” or
“Chemesis”), is pleased to announce, further to its news release dated January 27, 2020, that the Puerto
Rico Department of Health (the “ DHPR”), as a result of the previously announced favourable judgment
from the Puerto Rico Superior Court, San Juan (the “Decision”) (please see the news release dated January
17, 2020), has reinstated all cannabis cultivation and cannabis manufacturing licenses (the “ Licenses”)
held by its subsidiary, Natural Ventures PR, LLC (“ Natural Ventures”). The Decision, which is still under
appeal, found that such abeyance of the Licenses was invalid and unconstitutional and nullified such
action.
The Company notes that, at the current time, the Licenses have been reinstated to being operational, and
that Natural Ventures is permitted to carry out the licensed activities under the Licenses. The Compan y
will provide further updates as appropriate.
On Behalf of The Board of Directors
Edgar Montero
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated U.S. Multi -State operator with International
operations in Puerto Rico and Colombia.
The Company focuses on prudent capital allocation to ensure it maintains a first mover advantage as it
enters new markets and is committed to differentiate itself by deploying resources in markets with major
opportunities. The Company operates a portfolio of brands that cater to a wide community of cannabis
consumers, with focus on quality and consistency.
Chemesis has facilities in both Puerto Rico and California. The Company is positioned to win additional
licenses in highly competitive merit-based US states and will expand its footprint to ensure it maintains a
first mover advantage.
Investor Relations:
1 (604) 398-3378
Social Media:
Chemesis.facebook
Chemesis.twitter
Chemesis.instagram
DesertZen.instagram
GreenSpiritRX
Forward-Looking Information: This news release contains "forward -looking information" within the meaning of
applicable securities laws relating to statements regarding the Company's business, products an d future of the
Company’s business, its product offerings and plans for sales and marketing, the outcome of the appeal, its plans to
continue to develop dispensaries in Puerto Rico, and its ability to obtain licenses in additional jurisdictions. Although
the Company believes that the expectations reflected in the forward -looking information are reasonable, there can
be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance
on forward-looking information. Such forward -looking statements are subject to risks and uncertainties that may
cause actual results, performance and developments to differ materially from those contemplated by these
statements depending on, among other things, the risks that the Decision may be successfully appealed by the Puerto
Rico Department of Health, the appeal may not be resolved promptly, that the Company's products and plan will vary
from those stated in this news release and the Company may not be able to carry out its business plans as expected,
including, but not limited to, in relation to developing dispensaries in Puerto Rico, and its ability to obtain licenses in
additional jurisdictions. Except as required by law, the Company expressly disclaims any obligation and doe s not
intend to update any forward-looking statements or forward-looking information in this news release. Although the
Company believes that the expectations reflected in the forward -looking information are reasonable, there can be
no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales
reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release